The global genetic testing landscape has transitioned from a niche academic pursuit to a cornerstone of modern clinical diagnostics. As a leading CE Certified Genetic Testing Services Exporter, we recognize that the integration of genomics into routine healthcare is driving an unprecedented demand for high-throughput, accurate, and cost-effective molecular solutions. Beyond simple diagnostic kits, the industry now demands a synergistic ecosystem involving automated extraction, real-time quantification, and sophisticated bioinformatics.
The Genetic Testing market is projected to reach a multi-billion dollar valuation by 2030, fueled by the rising prevalence of chronic diseases and the aging global population. Emerging markets in the Asia-Pacific and Latin America are rapidly adopting PCR and NGS (Next-Generation Sequencing) technologies to bypass traditional, slower diagnostic methods. Our role as a global exporter involves not just shipping hardware, but ensuring Information Gain through localized technical support and training, bridging the gap between advanced technology and clinical application.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
BioX Medical focuses on the decentralization of molecular testing, moving from centralized massive labs to high-efficiency, automated 96-well systems like the BK-AUTOHS96. This reduces human error and optimizes turnaround time (TAT).
Incorporating AI algorithms for predictive analysis and variant interpretation. Our systems are evolving to provide not just data, but actionable clinical insights through cloud-based diagnostic platforms.
Miniaturization of Real-Time PCR systems, such as our Portable Fluorescence Detection Systems, allowing for gold-standard molecular diagnostics in rural or resource-limited environments.
Detecting genetic markers for targeted therapy. BioX systems support multi-gene panels to guide precision cancer treatment.
Rapid identification of pathogens using automated extraction and high-sensitivity PCR for public health surveillance.
Non-invasive prenatal testing (NIPT) and carrier screening solutions designed for prenatal clinics and maternity hospitals.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, BioX Medical continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards such as CE-IVD, ISO 13485, and regional regulatory requirements.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
BioX Medical
